RSS

Owlstone Medical

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. more

News

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy platform. more

News

Diagnostics company, Owlstone Medical, has announced that it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, for its Breath Biopsy platform. more

News

Diagnostics company, Owlstone Medical, has announced that GlaxoSmithKline (GSK) will incorporate its Breath Biopsy platform into the clinical development programme of danirixin — a novel GSK pipeline drug candidate for respiratory disease. more

Technology

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Science museum

Shutterstock.com

Diagnostics company, Owlstone Medical, has revealed that its breathalyser, ReCIVA, has been selected to be featured in the Tomorrow’s World gallery at the Science Museum in London. more

Technology

Diagnostics company, Owlstone Medical, and Cancer Research UK (CRUK) have initiated a trial that is focused on the identification of breath biomarkers for the early detection and diagnosis of various cancers. more

News

Founder and CEO of Owlstone Medical, Billy Boyle, has been announced as the winner of the Royal Academy of Engineering’s Silver Medal, which recognises his work in the development of the company’s Breath Biopsy platform. more

News

Diagnostics company, Owlstone Medical, who is developing a breathalyser for disease has announced it has signed a master service agreement with pharmaceutical company 4D Pharma. more

News